Skip to content

Circles

P

Precision Biosciences Inc

DTIL· Nasdaq

P

DTILPrecision Biosciences Inc

DTILPrecision Biosciences Inc·Earnings record

Q2 2018

Source filing unavailable

Previous · Q1 2018 Next · Q3 2018

Q2 2018 · —

Revenue

$1.87M

no prior Q2 2017 on file

Net Income

-$11.83M

no prior Q2 2017 on file

EPS Diluted

-$0.75

no prior Q2 2017 on file

Operating Income-$12,125,000—

Operating Cash Flowderived-$9,310,000—

Same quarter

no prior Q2 2017 on file

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Filing lag

Quarterly history

Q1 ’18Q2 ’18Q3 ’18 Q4 ’18^d Q1 ’19 Q2 ’19 Q3 ’19 Q4 ’19^d Q1 ’20…

Precision Biosciences Inc · CIK 1357874 · Engraved from SEC EDGAR

Free Cash Flowderived

-$10,438,000—

Margins · derived

Operating margin-647.0%

Net margin-631.1%

Thaler ResearchEngraved from SEC EDGAR© 2026 Thaler. All rights reserved.Last sale prices: Data provided for free by IEX. By accessing or using IEX Historical Data, you agree to the IEX Historical Data Terms of Use.

Platform

Using AI API SDKs CLI

Research

News Listen Earnings Insiders Holders Compare Metrics

Screener Watchlists Pies Notes Your companies

Learn

Thaler

Thaler Agent Promise Provenance Circles Account Terms Privacy